Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44777
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVANDORMAEL, Patrick-
dc.contributor.authorFADLALLAH, sukayna-
dc.contributor.authorRUYTINX, Pieter-
dc.contributor.authorPUES, Astrid-
dc.contributor.authorSLEURS, Ellen-
dc.contributor.authorLIESENBORGS, Jori-
dc.contributor.authorJoly, Johan-
dc.contributor.authorAGTEN, Anouk-
dc.contributor.authorVANDENABEELE, Frank-
dc.contributor.authorFRAUSSEN, Judith-
dc.contributor.authorVerschueren, Patrick-
dc.contributor.authorSOMERS, Veerle-
dc.date.accessioned2024-12-06T10:12:08Z-
dc.date.available2024-12-06T10:12:08Z-
dc.date.issued2024-
dc.date.submitted2024-12-04T14:31:13Z-
dc.identifier.citationRMD open, 10 (4) (Art N° e004743)-
dc.identifier.urihttp://hdl.handle.net/1942/44777-
dc.description.abstractTo discover antibody biomarkers that can predict a lack of response to first-line therapy in rheumatoid arthritis (RA) patients.-
dc.description.sponsorshipFunding This study was supported by grants from the Centre for Medical Innovation Flanders (Centrum voor Medische Innovatie, CMI) and the Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek, FWO). Acknowledgements We would like to thank Josianne Bleus and Igna Rutten (UHasselt, Biomedical Research Institute) for excellent technical support, Veerle Stouten (KULeuven, now Sciensano) for help with providing patient data, Liesbeth Bruckers (UHasselt, Data Science Institute, Center for Statistics) for excellent support with statistical analyses and the University Biobank Limburg (UBiLim) and the Biobank of University Hospitals Leuven for providing plasma/serum samples and clinical characteristics of RA patients and healthy controls.-
dc.language.isoen-
dc.publisher-
dc.rightsAuthor(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.-
dc.subject.otherTherapeutics-
dc.subject.otherArthritis, Rheumatoid-
dc.subject.otherAntibodies-
dc.subject.otherAutoimmune Diseases-
dc.titleFibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis-
dc.typeJournal Contribution-
dc.identifier.issue4-
dc.identifier.volume10-
local.format.pages16-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnre004743-
dc.identifier.doi10.1136/rmdopen-2024-004743-
dc.identifier.pmid39551578-
dc.identifier.isi001356630200001-
local.provider.typewosris-
local.uhasselt.internationalno-
item.accessRightsOpen Access-
item.contributorVANDORMAEL, Patrick-
item.contributorFADLALLAH, sukayna-
item.contributorRUYTINX, Pieter-
item.contributorPUES, Astrid-
item.contributorSLEURS, Ellen-
item.contributorLIESENBORGS, Jori-
item.contributorJoly, Johan-
item.contributorAGTEN, Anouk-
item.contributorVANDENABEELE, Frank-
item.contributorFRAUSSEN, Judith-
item.contributorVerschueren, Patrick-
item.contributorSOMERS, Veerle-
item.fullcitationVANDORMAEL, Patrick; FADLALLAH, sukayna; RUYTINX, Pieter; PUES, Astrid; SLEURS, Ellen; LIESENBORGS, Jori; Joly, Johan; AGTEN, Anouk; VANDENABEELE, Frank; FRAUSSEN, Judith; Verschueren, Patrick & SOMERS, Veerle (2024) Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis. In: RMD open, 10 (4) (Art N° e004743).-
item.fulltextWith Fulltext-
crisitem.journal.issn2056-5933-
crisitem.journal.eissn2056-5933-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early .pdfPublished version1.2 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.